PPMD Invests $1 Million in Satellos Bioscience to Support New Regenerative Medicine Technology
Parent Project Muscular Dystrophy is excited to announce a $1 million programmatic investment in Satellos Bioscience Inc. (Satellos) to support the development of a new regenerative medicine for the therapeutic treatment of Duchenne. Duchenne is…Learn More